ST-segment elevation myocardial infarction management in Europe.

Area of Science:

• Cardiology
• Public Health

Background:

• Significant variation exists in percutaneous coronary intervention (PCI) rates for ST-elevation myocardial infarction (STEMI) across European countries.
• Mortality rates following acute myocardial infarction also differ between European nations, influenced by treatment accessibility and timeliness.

Purpose of the Study:

• To analyze the factors contributing to variations in PCI rates and mortality for STEMI in Europe.
• To highlight the impact of delays in reperfusion therapy on patient outcomes.

Main Methods:

• Review of European healthcare systems and guidelines.
• Analysis of time delays from symptom onset to first medical contact and to reperfusion (thrombolysis or PCI).
• Examination of logistical factors affecting treatment delivery, including prehospital care and diagnostic procedures.

Main Results:

• Differences in time to treatment (symptom onset to first medical contact, first medical contact to reperfusion) are key factors in STEMI outcomes.
• Logistical delays in patient transport, diagnosis, and team preparation impact PCI availability.
• Integrated approaches, prehospital triage, and electrocardiogram transmission can significantly reduce door-to-balloon times.

Conclusions:

• Early reperfusion therapy, particularly PCI, is crucial for improving STEMI outcomes as emphasized by European Society of Cardiology guidelines.
• Addressing logistical delays through coordinated systems and prehospital interventions is essential to reduce door-to-balloon time and minimize ischemic complications.